for Identification of Cancer Essential Genes in Malignant Pleural - - PowerPoint PPT Presentation

for identification of cancer essential
SMART_READER_LITE
LIVE PREVIEW

for Identification of Cancer Essential Genes in Malignant Pleural - - PowerPoint PPT Presentation

Genome-Wide CRISPR-Cas9 Screening for Identification of Cancer Essential Genes in Malignant Pleural Mesothelioma Ece akrolu, MSc. Izmir Biomedicine and Genome Center & Dokuz Eylul University, Izmir International Biomedicine and


slide-1
SLIDE 1

Genome-Wide CRISPR-Cas9 Screening for Identification of Cancer Essential Genes in Malignant Pleural Mesothelioma

Izmir Biomedicine and Genome Center & Dokuz Eylul University, Izmir International Biomedicine and Genome Institute ece.cakiroglu@msfr.ibg.edu.tr

Ece Çakıroğlu, MSc.

Funded by TUBITAK, project no: 117Z227

slide-2
SLIDE 2

Malignant Pleural Mesothelioma

➢ 80-90% of mesothelioma cases ➢ Asbestos exposure

  • Irritation
  • Oxygen free radicals
  • Interfering mitosis
  • Inflammatory cytokines
  • Phosphorylation of protein kinases

➢ Rare ➢ Increasing incidance ➢ Late diagnosis ➢ Invasive character ➢ Poor survival

Bibby AC, Tsim S et al., Eur Respir Rev 2016 Kato S, Tomson BN et al., Mol Cancer Ther 2016

  • Multimodal/trimodal treatment ➔standard in the treatment of early-stage MPM
  • Poor prognosis
  • Low survival (~1-year mean survival; 9% 5-year survival )
  • Pemetrexed - a folic acid-like chemotherapeutic agent- (FDA approval in 2004)

28.10.2019 2

slide-3
SLIDE 3

Our Aim

Identification and Functional Characterization of Essential Genes Involved in the Development of Malignant Pleural Mesothelioma

Whole- Genome CRISPR Screen

28.10.2019 3

slide-4
SLIDE 4

Non-homologous end joining Homology directed repair

Jinek M, Chylinski K et al., Science 2012 Ran FA et al., Nature Protocols 2013 28.10.2019 4

slide-5
SLIDE 5

CRISPR Screens

28.10.2019 5

slide-6
SLIDE 6

Clonal and Stable Cas9 Expression

Transfection Infection Sorting

HEK293T

Cell Line 96-well plates seeded Obtained Clones

MeT-5A 9 12 H2052 15 13 H2452 6 12 H28 10 11 28.10.2019 6

slide-7
SLIDE 7

Choosing The Rig

ight Clo lone

MeT-5A H2052 H2452 H28

28.10.2019 7

slide-8
SLIDE 8

Met-5A Met-5A Clone 1 Met-5A Clone 2 Met-5A Clone 3 Met-5A Clone 4 Met-5A Clone 5 Flag α-tubulin H2452 H2452 Clone 1 H2452 Clone 2 H2452 Clone 4 H2452 Clone 6 H2452 Clone 9 H28 H28 Clone 11 H28 Clone 2 H28 Clone 4 H28 Clone 6 H28 Clone 5 H2052 H2052 Clone 13 H2052 Clone 4 H2052 Clone 5 H2052 Clone 12 H2052 Clone 8 Flag α-tubulin Flag α-tubulin Flag α-tubulin

Choosing The Rig

ight Clo lone

28.10.2019 8

slide-9
SLIDE 9

Testing Functionality of Cas9

Competition Assay

MeT-5A-Cas9 H2052-Cas9 lentiGuide-Hygro-dTomato-Ren g.208 H2452-Cas9 lentiGuide-Hygro-dTomato-RPA3 g.44 H28-Cas9

28.10.2019 9

slide-10
SLIDE 10

Addgene Senturk Perfectly Matching Guides (%) 93.5 93.6 Undetected Guides (%) 0.2 0.3 Skew Ratio 4.50 4.46

Lentiviral gRNA Library Amplification

NGS Result

LentiGuide-Puro plasmid backbone

76441 sgRNs Brunello gRNA Library Target sequence sgRNA

28.10.2019 10

slide-11
SLIDE 11

Large-Scale Virus Production

Brunello : psPAX2 : pMD2.G 4 : 2 : 1 DNA : PEI 1 : 5

MOI Calculation

MeT-5A ➔ 1/128 H28 ➔ 1/128 H2052 ➔ 1/48 H2452 ➔ 1/24

28.10.2019 11

slide-12
SLIDE 12

Sample collection T=0 T=7 T=14 NGS MOI Calculation

Bioinformatical Analysis Determining candidates Validation

28.10.2019 12

slide-13
SLIDE 13

THANK YOU FOR YOUR ATTENTION

  • Senturk Lab Members

-Özlem Şilan Coşkun -Aslı Kurden Pekmezci -Dilara Demirci -Bengisu Uluata Dayanç -F. Aybüke Mazı

  • Advisor

-Doç Dr. Şerif Şentürk

Funded by TUBITAK, project no: 117Z227

28.10.2019 13